Intellia Therapeutics, Inc.: Positive Opinion of Goldman Sachs







Marketzone with MT Newswires 2022

All the news about INTELLIA THERAPEUTICS, INC.

Analyst Recommendations for INTELLIA THERAPEUTICS, INC.

2022 turnover 43.5M

42.8M
2022 net result -457M

-450M
trso. net 2022 1,084M

1,067M
PER 2022-11.2x
2022 return
Capitalization 4,963M
4,963M
4,887M
VE / CA 202289.2x
VE / CA 202394.0x
Number of employees485
Floating90.2%

Chart INTELLIA THERAPEUTICS, INC.


Hard :

Period:




Intellia Therapeutics, Inc. : Intellia Therapeutics, Inc. Technical Analysis Chart |  Market area

Trends Technical Analysis INTELLIA THERAPEUTICS, INC.

Short termMiddle termLong term
TrendsbullishNeutralBearish

Evolution of the Income Statement

Sale

Purchase

Average recommendationTO BUY
Number of Analysts24
Last Closing Price$63.32
Average price target$124.38
Deviation / Average Target96.4%

Officers and Directors




Source link -88